The World

Since 2001, when a federal funding freeze crippled research into the use of human embryonic stem cells to treat a host of congenital and degenerative conditions, molecular biologists have searched for a viable alternative. Now, they may have found a way. By reprogramming adult skin cells, researchers have produced stem cells that bypass the political and ethical stumbling blocks. But all is not perfect. In recent studies, the cells produced tumors in mice. Guest: Dr. George Daley, associate director of the Stem Cell Program, Children’s Hospital Boston.

Invest in independent global news

The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. Will you support The World with a gift today? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!